ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

Novartis Plans CHF500 Million New Manufacturing Facility

ZURICH -(Dow Jones)- Swiss pharmaceutical company Novartis AG (NVS) said Monday it is planning to invest over 500 million Swiss francs ($550 million) building a new manufacturing facility in Switzerland. MAIN FACTS: -The company said the investment underlines the long-term strategy of Novartis to establish a worldwide manufacturing network of technology centers. -The new production site in Stein, Switzerland, is expected to be fully operational by end of 2016. -"This investment is further strengthening the importance of Stein as Manufacturing Center of Excellence for sterile and solid dosage forms and will play a key role in our global production network," said Joseph Jimenez, CEO of Novartis. "It also strengthens our presence in Switzerland, which remains a center of key importance for Novartis." -The Stein site in Canton Aargau is the largest production facility of the Pharmaceuticals Division. Every year, the approximately 1,400 associates at the site produce over 4.1 billion tablets, capsules, ampoules, prefilled syringes, vials and transdermal therapeutic systems, which are exported to over 150 countries. -The new set-up will allow Novartis to adapt its production capacity more quickly depending on an evolving portfolio and market demand. The center will serve approximately 150 markets globally. -Zurich Bureau, Dow Jones Newswires, +41 43 443 80 47; zurichdjnews@dowjones.com

Stock News for Novartis (NVS)
DateTimeHeadline
04/24/201417:35:36ADR Shares End Mixed; Unilever, AstraZeneca Shares Active
04/24/201415:35:42U.S. Stocks Rise, Buoyed by Apple Results
04/24/201415:20:17Lilly Says Takeda May Not Cover Its Share of $9 Billion Lawsuit
04/24/201412:39:32Novartis Leads Zurich Stocks Lower
04/24/201412:37:47EUROPE MARKETS: European Stocks End Choppy Day In Black
04/24/201410:39:52EUROPE MARKETS: European Stocks Pare Gains On Ukraine Tensions
04/24/201408:00:28Zimmer to Buy Biomet for $13.35 Billion -- Update
04/24/201406:18:32EUROPE MARKETS: European Stocks Strong After Ifo, Draghi Comments
04/24/201404:30:12Novartis 1Q Profit Rises About 23%
04/24/201402:40:06Novartis 1st Quarter Profit Rises About 23%
04/24/201402:27:06Novartis First-Quarter Profit Rises About 23% -- Update
04/22/201413:06:07LONDON MARKETS: Glaxo, AstraZeneca Lead U.K. Stocks To Two-week...
04/22/201412:38:25EUROPE MARKETS: Drug Stocks Drive European Markets Higher
04/22/201412:35:06Novartis 1Q 2014 -- Forecast
04/22/201409:50:05Glaxo Exits Cancer Drugs
04/22/201409:44:35LONDON MARKETS: Glaxo, AstraZeneca Lead Gains In U.K. Stocks
04/22/201409:34:59U.S. Stock Futures Trade Flat
04/22/201408:32:05Novartis Overhauls Portfolio With Deals Worth $25 Billion...
04/22/201405:51:23Novartis Overhauls Portfolio With Deals Worth $25 Billion...
04/22/201404:40:14European Stocks Start Strongly After Easter Holiday

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad